Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Anavex Life Sciences Corp. (AVXL) Message Board

Below copied from IHUB… Just maybe we are gettin

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 1460
(Total Views: 267)
Posted On: 07/29/2024 10:48:06 AM
Posted By: fletch
Below copied from IHUB… Just maybe we are getting closer to seeing our Anavex approved,
Fletch

falconer66a
Re: plexrec post# 465356
Monday, July 29, 2024 10:02:49 AM
Post# of 465434
When Useful, Will Post on Anavex Science
falconer---care to chime in ?? Yesterday's Presentation ??????

I’ve restrained my postings in recent months (regarding blarcamesine, Anavex, etc.). Those familiar with my postings know that I have a rather complete understanding of the cellular physiology of the mechanisms of actions (MOAs) of the Anavex sigma-1 receptor activators. So very different from and so far more effective than the MAB (monoclonal antibody) competitors; and are more easily administered (orally), without AEs, adverse events; side effects. No brain hemorrhaging, no brain shrinkage. And more.

In anticipation of this presentation, a week ago I expanded my AVXL position. Had some discretionary dollars; which with my now slightly larger AVXL position have appreciated nicely — a share price gain that I contend will continue in the following weeks and months. Then, application for blarcamesine approval in the EMA. With that, future AVXL price appreciations will no longer be speculation. Schizophrenia approval will follow; will be BIG.

All of the usual AVXL naysayers are working hard at their keyboards to post reasons why, once again, as always before, Anavex will fail. I’m not going to waste my time trying negate their quasi-scientific Anavex naysayings. The “market” will prevail. Will be interested to see what the real investment experts, at the New York Times, for example, will be saying. Will general news media have stories to the effect, “New Drug Candidate Gives Real Hope for Alzheimer’s?” Should they appear, how will the public react to such news articles?

We’ll all be watching. When there’s some science I can usefully comment on, I’ll post it. Until then, I and my few AVXL friends will privately share our understandings. Things Anavex coming together just as expected.

https://investorshub.advfn.com/Anavex-Life-Sc...AVXL-11474


(2)
(0)




Anavex Life Sciences Corp. (AVXL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us